After last year’s highly successful inaugural session, the MaRS Future of Medicine™ Conference returned on December 2nd for its second amazing year! Focused on two high impact themes in medicine (personalized medicine and infectious disease), the 2010 conference highlighted powerful healthcare solutions developed by leading Ontario innovators.
Dr. Aled Edwards, Director and CEO of the Structural Genomics Consortium, talks about drug development and new approaches that could create better drugs more cheaply.
MaRS - Building Canada’s next generation of global technology companies. marsdd.com